Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Comparison of Light Transmission Aggregometry and VerifyNow in Detecting Clopidogrel Resistance and Factors Affecting Clopidogrel Resistance in AMI-EST Patients Undergoing Percutaneous Coronary Intervention: A Cross-Sectional Study

The Indonesian Biomedical Journal · Vol. 13 No. 2 (2021) · hlm. 163–169

DOI
10.18585/inabj.v13i2.1477
ISSN
2085-3297, 2355-9179
Terbit
2021-06-14
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Light transmission aggregometry (LTA) and VerifyNow is commonly used to measure platelet responsiveness to clopidogrel. This study aimed to compare the results of LTA and VerifyNow P2Y12 assay for assessing the clopidogrel resistance in patients undergoing percutaneous coronary intervention and determine factors affecting clopidogrel resistance.METHODS: The subjects were 119 patients who underwent percutaneous coronary intervention (PCI) and had given loading dose of 600 mg clopidogrel. Blood samples were taken at 6 hour after clopidogrel loading dose. Platelet aggregation was measured by LTA and VerifyNow.RESULTS: LTA and VerifyNow assay showed fair agreement with Kappa=0.270, p=0.001. The proportion of resistance to clopidogrel using VerifyNow was 21.8% and LTA was 47.1%. Patients with diabetes melitus were more likely to develop clopidogrel resistance than patients without diabetes (OR of 7.67; 95% CI: 1.87-31.50; p=0.005).CONCLUSION: The ability of LTA and VerifyNow in detecting clopidogrel resistance were not comparable. Multivariate analysis results for VerifyNow shows diabetes mellitus as the greatest predictors of clopidogrel resistance.KEYWORDS: agreement, clopidogrel resistance, LTA, predictor, VerifyNow

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 186 tautan kepenulisan bersama · 128 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
  • Universitas Muhammadiyah Prof Dr Hamka
  • Pembuluh Darah Harapan Kita
  • Universitas Trisakti
  • Fatmawati Hospital
  • Krida Wacana Christian University
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Dewi WulandariRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo5
Todung Donald Aposan SilalahiKrida Wacana Christian University3
Suhendro SuwartoRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo3
Saptawati BardosonoUniversity of Indonesia3
Suzanna ImmanuelRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo3
Ferry SandraUniversitas Trisakti3
Em YunirUniversity of Indonesia2
Sarwono WaspadjiRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Ronald Winardi KartikaUniversity of Indonesia2
Franciscus Dhyanagiri SuyatnaUniversity of Indonesia2
Saleha SungkarUniversity of Indonesia2
Jusuf RachmatUniversity of Indonesia2
Mirta Hediyati ReksodiputroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Frans Dhyanagiri SuyatnaUniversity of Indonesia2
Fery ArdiansahUniversitas Muhammadiyah Prof Dr Hamka1
Endin Nokik StujannaUniversitas Muhammadiyah Prof Dr Hamka1
Arief Indra SanjayaUniversitas Muhammadiyah Prof Dr Hamka1
Sri Suciati NingsihBadan Pengkajian dan Penerapan Teknologi1
Irena UjiantiUniversitas Muhammadiyah Prof Dr Hamka1
Dwi LestariUniversitas Muhammadiyah Prof Dr Hamka1
Amal Chalik SjaafUniversity of Indonesia1
Masyitoh MasyitohState University of Semarang1
Zhafirah SalsabilaUniversity of Indonesia1
Elisna SyahruddinUniversity of Indonesia1
Rita KhairaniUniversitas Trisakti1
Elly HerwanaUniversitas Trisakti1
Sidartawan SoegondoUniversity of Indonesia1
Ali BaziadUniversity of Indonesia1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Comparison of Light Transmission Aggregometry and VerifyNow in Detecting Clopidogrel Resistance and Factors Affecting Clopidogrel Resistance in AMI-EST Patients Undergoing Percutaneous Coronary Intervention: A Cross-Sectional Study</dc:title><dc:creator>Astuti Giantini</dc:creator><dc:creator>Ina Susianti Timan</dc:creator><dc:creator>Erlin Listiyaningsih</dc:creator><dc:creator>Rahajuningsih S Dharma</dc:creator><dc:creator>Rianto Setiabudy</dc:creator><dc:creator>Idrus Alwi</dc:creator><dc:creator>Lia Gardenia Partakusuma</dc:creator><dc:creator>Nuri Dyah Indrasari</dc:creator><dc:creator>Alida Roswita Harahap</dc:creator><dc:creator>Siskawati Suparmin</dc:creator><dc:creator>Windy Sahar</dc:creator><dc:creator>Renan Sukmawan</dc:creator><dc:subject>clopidogrel resistance</dc:subject><dc:subject>light transmission aggregometry</dc:subject><dc:subject>VerifyNow P2Y12 assay</dc:subject><dc:subject>platelet aggregation</dc:subject><dc:subject>percutaneous coronary intervention</dc:subject><dc:subject>acute myocardial infarction</dc:subject><dc:subject>diabetes mellitus</dc:subject><dc:subject>P2Y12 inhibitors</dc:subject><dc:subject>test agreement</dc:subject><dc:description xml:lang="en">BACKGROUND: Light transmission aggregometry (LTA) and VerifyNow is commonly used to measure platelet responsiveness to clopidogrel. This study aimed to compare the results of LTA and VerifyNow P2Y12 assay for assessing the clopidogrel resistance in patients undergoing percutaneous coronary intervention and determine factors affecting clopidogrel resistance.METHODS: The subjects were 119 patients who underwent percutaneous coronary intervention (PCI) and had given loading dose of 600 mg clopidogrel. Blood samples were taken at 6 hour after clopidogrel loading dose. Platelet aggregation was measured by LTA and VerifyNow.RESULTS: LTA and VerifyNow assay showed fair agreement with Kappa=0.270, p=0.001. The proportion of resistance to clopidogrel using VerifyNow was 21.8% and LTA was 47.1%. Patients with diabetes melitus were more likely to develop clopidogrel resistance than patients without diabetes (OR of 7.67; 95% CI: 1.87-31.50; p=0.005).CONCLUSION: The ability of LTA and VerifyNow in detecting clopidogrel resistance were not comparable. Multivariate analysis results for VerifyNow shows diabetes mellitus as the greatest predictors of clopidogrel resistance.KEYWORDS: agreement, clopidogrel resistance, LTA, predictor, VerifyNow</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2021-06-14</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v13i2.1477</dc:identifier><dc:identifier>10.18585/inabj.v13i2.1477</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 13 No 2 (2021); 163-169</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/1477/528</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>